首页> 外文期刊>Chemical science >Rational design of a “dual lock-and-key” supramolecular photosensitizer based on aromatic nucleophilic substitution for specific and enhanced photodynamic therapy
【24h】

Rational design of a “dual lock-and-key” supramolecular photosensitizer based on aromatic nucleophilic substitution for specific and enhanced photodynamic therapy

机译:基于芳族亲核性替代特异性和增强光动力疗法的“双锁和关键”超分子光敏剂的理性设计

获取原文
           

摘要

Photosensitizing agents are essential for precise and efficient photodynamic therapy (PDT). However, most of the conventional photosensitizers still suffer from limitations such as aggregation-caused quenching (ACQ) in physiological environments and toxic side-effects on normal tissues during treatment, leading to reduced therapeutic efficacy. Thus, integrating excellent photophysical properties and accurate carcinoma selectivity in a photosensitizer system remains highly desired. Herein, a “dual lock-and-key” supramolecular photosensitizer BIBCl–PAE NPs for specific and enhanced cancer therapy is reported. BIBCl–PAE NPs are constructed by encapsulating a rationally designed glutathione (GSH)-activatable photosensitizer BIBCl in a pH-responsive diblock copolymer. In normal tissues, BIBCl is “locked” in the hydrophobic core of the polymeric micelles due to ACQ. Under the “dual key” activation of low pH and high levels of GSH in a tumor microenvironment, the disassembly of micelles facilitates the reaction of BIBCl with GSH to release water-soluble BIBSG with ideal biocompatibility, enabling the highly efficient PDT. Moreover, benefiting from the F?rster resonance energy transfer effect of BIBSG, improved light harvesting ability and ~(1) O _(2) production are achieved. In vitro and vivo experiments have demonstrated that BIBCl–PAE NPs are effective in targeting and inhibiting carcinoma. BIBCl–PAE NPs show superior anticancer efficiency relative to non-activatable controls.
机译:光敏剂对于精确高效的光动力治疗(PDT)至关重要。然而,大多数常规光敏剂仍然遭受局限性,例如在治疗期间对生理环境中的聚集导致猝灭(ACQ)毒性副作用,导致治疗疗效降低。因此,在光敏剂系统中整合出优异的光学性质和精确的癌选择性仍然非常需要。这里,报道了针对特异性和增强的癌症治疗的“双锁和键”超分子光敏剂Bibcl-PAE NPS。通过将合理设计的谷胱甘肽(GSH)-Activatable的光敏剂Bibcl封装在pH-响应二嵌段共聚物中,构建Bibcl-Pae NP。在正常组织中,由于ACQ,Bibcl在聚合物胶束的疏水芯中“锁定”。在肿瘤微环境中低pH和高水平GSH的“双关键”激活下,胶束的拆卸有助于Bibcl与GSH的反应释放水溶性Bibsg,具有理想的生物相容性,使得能够高效的PDT。此外,从F?脊柱螺母共振能量转移效应的益处,改善了光收获能力和〜(1)o _(2)的生产。体外和体内实验表明Bibcl-Pae NPS在靶向和抑制癌中是有效的。 Bibcl-PAE NPS相对于不可激活的控制显示出优异的抗癌效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号